Found: 15
Select item for more details and to access through your institution.
Cortical hyperexcitability in mouse models and patients with amyotrophic lateral sclerosis is linked to noradrenaline deficiency.
- Published in:
- Science Translational Medicine, 2024, v. 16, n. 738, p. 1, doi. 10.1126/scitranslmed.adg3665
- By:
- Publication type:
- Article
Integrative genetic analysis illuminates ALS heritability and identifies risk genes.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-022-35724-1
- By:
- Publication type:
- Article
Degeneration of serotonin neurons triggers spasticity in amyotrophic lateral sclerosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Motor neuron intrinsic and extrinsic mechanisms contribute to the pathogenesis of FUS-associated amyotrophic lateral sclerosis.
- Published in:
- Acta Neuropathologica, 2017, v. 133, n. 6, p. 887, doi. 10.1007/s00401-017-1687-9
- By:
- Publication type:
- Article
Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis.
- Published in:
- Acta Neuropathologica, 2016, v. 131, n. 3, p. 465, doi. 10.1007/s00401-016-1534-4
- By:
- Publication type:
- Article
Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis.
- Published in:
- Acta Neuropathologica, 2023, v. 145, n. 6, p. 773, doi. 10.1007/s00401-023-02569-x
- By:
- Publication type:
- Article
Cytoplasmic FUS triggers early behavioral alterations linked to cortical neuronal hyperactivity and inhibitory synaptic defects.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-23187-9
- By:
- Publication type:
- Article
In‐depth analysis of data from the RAS‐ALS study reveals new insights in rasagiline treatment for amyotrophic lateral sclerosis.
- Published in:
- European Journal of Neurology, 2024, v. 31, n. 4, p. 1, doi. 10.1111/ene.16204
- By:
- Publication type:
- Article
Low dietary protein content alleviates motor symptoms in mice with mutant dynactin/dynein-mediated neurodegeneration.
- Published in:
- Human Molecular Genetics, 2015, v. 24, n. 8, p. 2228, doi. 10.1093/hmg/ddu741
- By:
- Publication type:
- Article
Evaluation of a 5-HT<sub>2B</sub> receptor agonist in a murine model of amyotrophic lateral sclerosis.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-02900-0
- By:
- Publication type:
- Article
Author Correction: Integrative genetic analysis illuminates ALS heritability and identifies risk genes.
- Published in:
- 2023
- By:
- Publication type:
- Correction Notice
Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulation.
- Published in:
- Molecular Neurodegeneration, 2021, v. 16, n. 1, p. 1, doi. 10.1186/s13024-021-00477-w
- By:
- Publication type:
- Article
Wild-type FUS corrects ALS-like disease induced by cytoplasmic mutant FUS through autoregulation.
- Published in:
- Molecular Neurodegeneration, 2021, v. 16, n. 1, p. 1, doi. 10.1186/s13024-021-00477-w
- By:
- Publication type:
- Article
Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Toxic gain of function from mutant FUS protein is crucial to trigger cell autonomous motor neuron loss.
- Published in:
- EMBO Journal, 2016, v. 35, n. 10, p. 1077, doi. 10.15252/embj.201592559
- By:
- Publication type:
- Article